Logo image of EWL.DE

EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:EWL - US28176E1082 - Common Stock

71.66 EUR
-1.14 (-1.57%)
Last: 1/12/2026, 7:00:00 PM
Fundamental Rating

7

EWL gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 68 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making EWL a very profitable company, without any liquidiy or solvency issues. EWL is quite expensive at the moment. It does show a decent growth rate. These ratings could make EWL a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year EWL was profitable.
EWL had a positive operating cash flow in the past year.
In the past 5 years EWL has always been profitable.
Each year in the past 5 years EWL had a positive operating cash flow.
EWL.DE Yearly Net Income VS EBIT VS OCF VS FCFEWL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

EWL has a Return On Assets of 10.31%. This is amongst the best in the industry. EWL outperforms 88.24% of its industry peers.
Looking at the Return On Equity, with a value of 13.40%, EWL is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
EWL has a Return On Invested Capital of 9.83%. This is in the better half of the industry: EWL outperforms 75.00% of its industry peers.
EWL had an Average Return On Invested Capital over the past 3 years of 12.44%. This is above the industry average of 9.73%.
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROIC 9.83%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
EWL.DE Yearly ROA, ROE, ROICEWL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

EWL's Profit Margin of 23.25% is amongst the best of the industry. EWL outperforms 91.18% of its industry peers.
In the last couple of years the Profit Margin of EWL has grown nicely.
With an excellent Operating Margin value of 27.73%, EWL belongs to the best of the industry, outperforming 95.59% of the companies in the same industry.
In the last couple of years the Operating Margin of EWL has remained more or less at the same level.
The Gross Margin of EWL (78.19%) is better than 92.65% of its industry peers.
EWL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
EWL.DE Yearly Profit, Operating, Gross MarginsEWL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

10

2. Health

2.1 Basic Checks

EWL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
EWL has less shares outstanding than it did 1 year ago.
The number of shares outstanding for EWL has been reduced compared to 5 years ago.
The debt/assets ratio for EWL has been reduced compared to a year ago.
EWL.DE Yearly Shares OutstandingEWL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
EWL.DE Yearly Total Debt VS Total AssetsEWL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

EWL has an Altman-Z score of 12.44. This indicates that EWL is financially healthy and has little risk of bankruptcy at the moment.
EWL's Altman-Z score of 12.44 is amongst the best of the industry. EWL outperforms 95.59% of its industry peers.
The Debt to FCF ratio of EWL is 0.75, which is an excellent value as it means it would take EWL, only 0.75 years of fcf income to pay off all of its debts.
EWL's Debt to FCF ratio of 0.75 is amongst the best of the industry. EWL outperforms 91.18% of its industry peers.
EWL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
EWL has a Debt to Equity ratio of 0.06. This is amongst the best in the industry. EWL outperforms 85.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Altman-Z 12.44
ROIC/WACC0.99
WACC9.89%
EWL.DE Yearly LT Debt VS Equity VS FCFEWL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

EWL has a Current Ratio of 4.00. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
EWL's Current ratio of 4.00 is amongst the best of the industry. EWL outperforms 91.18% of its industry peers.
EWL has a Quick Ratio of 3.29. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of EWL (3.29) is better than 91.18% of its industry peers.
Industry RankSector Rank
Current Ratio 4
Quick Ratio 3.29
EWL.DE Yearly Current Assets VS Current LiabilitesEWL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

The earnings per share for EWL have decreased by -3.75% in the last year.
Measured over the past 5 years, EWL shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
The Revenue has been growing slightly by 4.67% in the past year.
The Revenue has been growing slightly by 4.58% on average over the past years.
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%

3.2 Future

The Earnings Per Share is expected to grow by 9.40% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.47% on average over the next years. This is quite good.
EPS Next Y1.51%
EPS Next 2Y6.17%
EPS Next 3Y7.9%
EPS Next 5Y9.4%
Revenue Next Year4.63%
Revenue Next 2Y7.13%
Revenue Next 3Y8.01%
Revenue Next 5Y8.47%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EWL.DE Yearly Revenue VS EstimatesEWL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
EWL.DE Yearly EPS VS EstimatesEWL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

EWL is valuated quite expensively with a Price/Earnings ratio of 32.43.
EWL's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.25. EWL is around the same levels.
With a Price/Forward Earnings ratio of 28.25, EWL can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EWL is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 23.98. EWL is around the same levels.
Industry RankSector Rank
PE 32.43
Fwd PE 28.25
EWL.DE Price Earnings VS Forward Price EarningsEWL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EWL is valued a bit more expensive than the industry average as 63.24% of the companies are valued more cheaply.
EWL's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 60.55
EV/EBITDA 25.18
EWL.DE Per share dataEWL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of EWL may justify a higher PE ratio.
PEG (NY)21.44
PEG (5Y)4.55
EPS Next 2Y6.17%
EPS Next 3Y7.9%

0

5. Dividend

5.1 Amount

EWL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

EDWARDS LIFESCIENCES CORP

FRA:EWL (1/12/2026, 7:00:00 PM)

71.66

-1.14 (-1.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-04 2026-02-04/amc
Inst Owners89.94%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap41.58B
Revenue(TTM)5.88B
Net Income(TTM)1.37B
Analysts79.52
Price Target81.68 (13.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)2
Avg Revenue beat(12)-2.12%
Revenue beat(16)2
Avg Revenue beat(16)-2.48%
PT rev (1m)0%
PT rev (3m)6.59%
EPS NQ rev (1m)-0.06%
EPS NQ rev (3m)0.81%
EPS NY rev (1m)0.07%
EPS NY rev (3m)3.32%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)0.19%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.94%
Valuation
Industry RankSector Rank
PE 32.43
Fwd PE 28.25
P/S 8.23
P/FCF 60.55
P/OCF 47.61
P/B 4.74
P/tB 6.63
EV/EBITDA 25.18
EPS(TTM)2.21
EY3.08%
EPS(NY)2.54
Fwd EY3.54%
FCF(TTM)1.18
FCFY1.65%
OCF(TTM)1.51
OCFY2.1%
SpS8.71
BVpS15.11
TBVpS10.81
PEG (NY)21.44
PEG (5Y)4.55
Graham Number27.41
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROCE 13.97%
ROIC 9.83%
ROICexc 14.65%
ROICexgc 23.24%
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
FCFM 13.59%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Debt/EBITDA 0.33
Cap/Depr 138.79%
Cap/Sales 3.69%
Interest Coverage 250
Cash Conversion 56.86%
Profit Quality 58.45%
Current Ratio 4
Quick Ratio 3.29
Altman-Z 12.44
F-Score6
WACC9.89%
ROIC/WACC0.99
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
EPS Next Y1.51%
EPS Next 2Y6.17%
EPS Next 3Y7.9%
EPS Next 5Y9.4%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
Revenue Next Year4.63%
Revenue Next 2Y7.13%
Revenue Next 3Y8.01%
Revenue Next 5Y8.47%
EBIT growth 1Y4.68%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year13%
EBIT Next 3Y12.27%
EBIT Next 5Y12.3%
FCF growth 1Y1.45%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-2.42%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%

EDWARDS LIFESCIENCES CORP / EWL.DE FAQ

Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?

ChartMill assigns a fundamental rating of 7 / 10 to EWL.DE.


What is the valuation status of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.


What is the profitability of EWL stock?

EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 8 / 10.


What are the PE and PB ratios of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 32.43 and the Price/Book (PB) ratio is 4.74.